[1]
Colacino, L., Magalhães, F.W. and Degenszajn, R.D. 2024. Contributions to public consultations and reversals of recommendations by Conitec: an analysis of drugs incorporated for the treatment of rare diseases. Boletim do Instituto de Saúde - BIS. 25, 2 (Nov. 2024), 69–78. DOI:https://doi.org/10.52753/bis.v25i2.41409.